Angiodynamics Inc: Form 10-K for the period ended May 31, 2013
Filed with the SEC on Aug 14, 2013 and accepted by EDGAR at Aug 14, 2013, 17:29 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2013-05-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2013-03-01 to 2013-05-31 | $90.0m | us-gaap:SalesRevenueNet |
| Revenue | 12 months2012-06-01 to 2013-05-31 | $342.0m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2012-06-01 to 2013-05-31 | $173.0m | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2013-03-01 to 2013-05-31 | $44.2m | us-gaap:GrossProfit |
| Gross profit | 12 months2012-06-01 to 2013-05-31 | $169.0m | us-gaap:GrossProfit |
| Research and development | 12 months2012-06-01 to 2013-05-31 | $26.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2012-06-01 to 2013-05-31 | $7.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2012-06-01 to 2013-05-31 | $5.3m | us-gaap:InterestExpense |
| Income tax | 12 months2012-06-01 to 2013-05-31 | −$31.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2013-03-01 to 2013-05-31 | −$868.0k | us-gaap:NetIncomeLoss |
| Net income | 12 months2012-06-01 to 2013-05-31 | −$612.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2013-03-01 to 2013-05-31 | −$0.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2012-06-01 to 2013-05-31 | −$0.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2013-03-01 to 2013-05-31 | −$0.03 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2012-06-01 to 2013-05-31 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2012-06-01 to 2013-05-31 | 34,817,279 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2012-06-01 to 2013-05-31 | $26.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2012-06-01 to 2013-05-31 | $12.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2012-06-01 to 2013-05-31 | $0 | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2013-05-31 | $21.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2013-05-31 | $141.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2013-05-31 | $791.6m | us-gaap:Assets |
| Current liabilities | At period end2013-05-31 | $63.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2013-05-31 | $264.8m | us-gaap:Liabilities |
| Long-term debt | At period end2013-05-31 | $135.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2013-05-31 | $7.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2013-05-31 | $526.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-13-334608. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.